Extended Input Deadline for USP´s new Chapter on Quality Considerations for Cannabis
Register now for ECA's GMP Newsletter
Following the previously announced elaboration of a new USP chapter <1568> Quality Considerations for Cannabis and Cannabis-derived Products for Clinical Research the input deadline has been extended to 31 July 2022.
USP is requesting early input from stakeholders on the proposed new General Chapter <1568> which is then expected to be published for comment in Pharmacopeial Forum.
More Information is available at the USP Compendial Notices Website.
Related GMP News
10.09.2025Final Revised GACP Guideline Published
28.08.2025Draft Public Statement on Cannabis Flos
28.08.2025Revised Ph. Eur. Cannabis Monograph
24.07.2025German Draft Act to amend Cannabis Prescription
24.07.2025Revised USP Chapter <561> Articles of Botanical Origin